Head and Neck Squamous Cell Carcinoma Clinical Trials in Dongguan
3 recruitingDongguan, China
Showing 1–3 of 3 trials
Recruiting
Phase 3
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Locally Advanced Head and Neck Squamous Cell CarcinomaAged
Johnson & Johnson Enterprise Innovation Inc.500 enrolled189 locationsNCT04892173
Recruiting
Phase 2
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
Cervical CancerHead and Neck Squamous Cell Carcinoma
AstraZeneca110 enrolled50 locationsNCT06535607
Recruiting
Phase 2
The Efficacy and Safety of Neoadjuvant Low-dose Radiotherapy Combined With Chemoimmunotherapy in Locally Advanced HNSCC
Head and Neck Squamous Cell CarcinomaNeoadjuvant Treatment
Fifth Affiliated Hospital, Sun Yat-Sen University25 enrolled2 locationsNCT05343325